{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:24:29Z","timestamp":1792185869410,"version":"4.4.0"},"reference-count":145,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Stuart Nichols ALS Research Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Immunity to viruses requires an array of critical cellular proteins that include IFN regulatory factor 3 (IRF3). Consequently, most viruses that infect vertebrates encode proteins that interfere with IRF3 activation. This review describes the cellular pathways linked to IRF3 activation and where those pathways are targeted by human viral pathogens. Moreover, key regulatory pathways that control IRF3 are discussed. Besides viral infections, IRF3 is also involved in resistance to some bacterial infections, in anticancer immunity, and in anticancer therapies involving DNA damage agents. A recent finding shows that IRF3 is needed for T cell effector functions that are involved in anticancer immunity and also in T cell autoimmune diseases. In contrast, unregulated IRF3 activity is clearly not beneficial, considering it is implicated in certain interferonopathies, in which heightened IRF3 activity leads to IFN-\u03b2\u2013induced disease. Therefore, IRF3 is involved largely in maintaining health but sometimes contributing to disease.<\/jats:p>","DOI":"10.4049\/jimmunol.2000462","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T01:30:24Z","timestamp":1601947824000},"page":"1981-1989","source":"Crossref","is-referenced-by-count":82,"title":["IFN Regulatory Factor 3 in Health and Disease"],"prefix":"10.1093","volume":"205","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6163-4854","authenticated-orcid":false,"given":"Thomas M","family":"Petro","sequence":"first","affiliation":[{"name":"Department of Oral Biology, University of Nebraska Medical Center , Lincoln, NE 68583 ; and , Lincoln, NE 68583"},{"name":"Nebraska Center for Virology, University of Nebraska Medical Center , Lincoln, NE 68583 ; and , Lincoln, NE 68583"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,10,15]]},"reference":[{"key":"2025030417505200800_r1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1097-2765(00)80051-9","article-title":"Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. [Published erratum appears in 1999 Mol. Cell 3: 813.]","volume":"1","author":"Wathelet","year":"1998","journal-title":"Mol. Cell"},{"key":"2025030417505200800_r2","doi-asserted-by":"crossref","first-page":"11657","DOI":"10.1073\/pnas.92.25.11657","article-title":"Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes","volume":"92","author":"Au","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030417505200800_r3","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1038\/s41598-020-61365-9","article-title":"Adaptations of interferon regulatory factor 3 with transition from terrestrial to aquatic life","volume":"10","author":"Angeletti","year":"2020","journal-title":"Sci. Rep."},{"key":"2025030417505200800_r4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0030106","article-title":"Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms","volume":"3","author":"Daffis","year":"2007","journal-title":"PLoS Pathog."},{"key":"2025030417505200800_r5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.virusres.2013.10.003","article-title":"IRF3 helps control acute TMEV infection through IL-6 expression but contributes to acute hippocampus damage following TMEV infection","volume":"178","author":"Moore","year":"2013","journal-title":"Virus Res."},{"key":"2025030417505200800_r6","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1165\/rcmb.2010-0288OC","article-title":"Pharmacologic activation of the innate immune system to prevent respiratory viral infections","volume":"45","author":"Cheng","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2025030417505200800_r7","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.3748\/wjg.v13.i17.2446","article-title":"The interferon inducing pathways and the hepatitis C virus","volume":"13","author":"Meurs","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"2025030417505200800_r8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1359-6101(97)00019-1","article-title":"The growing family of interferon regulatory factors","volume":"8","author":"Nguyen","year":"1997","journal-title":"Cytokine Growth Factor Rev."},{"key":"2025030417505200800_r9","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1093\/nar\/17.8.3292","article-title":"Sequence of a cDNA coding for human IRF-1","volume":"17","author":"Maruyama","year":"1989","journal-title":"Nucleic Acids Res."},{"key":"2025030417505200800_r10","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0092-8674(88)91307-4","article-title":"Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements","volume":"54","author":"Miyamoto","year":"1988","journal-title":"Cell"},{"key":"2025030417505200800_r11","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1093\/nar\/20.11.2877","article-title":"Distinct activation of murine interferon-alpha promoter region by IRF-1\/ISFG-2 and virus infection","volume":"20","author":"Au","year":"1992","journal-title":"Nucleic Acids Res."},{"key":"2025030417505200800_r12","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1128\/iai.63.2.601-608.1995","article-title":"Differential expression of interferon regulatory factor 1 (IRF-1), IRF-2, and interferon consensus sequence binding protein genes in lipopolysaccharide (LPS)-responsive and LPS-hyporesponsive macrophages","volume":"63","author":"Barber","year":"1995","journal-title":"Infect. Immun."},{"key":"2025030417505200800_r13","doi-asserted-by":"crossref","first-page":"8555","DOI":"10.1073\/pnas.87.21.8555","article-title":"ISGF3, the transcriptional activator induced by interferon alpha, consists of multiple interacting polypeptide chains","volume":"87","author":"Fu","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030417505200800_r14","first-page":"588","article-title":"Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription","volume":"13","author":"Nelson","year":"1993","journal-title":"Mol. Cell. Biol."},{"key":"2025030417505200800_r15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1365-2443.1996.08008.x","article-title":"Essential and non-redundant roles of p48 (ISGF3 gamma) and IRF-1 in both type I and type II interferon responses, as revealed by gene targeting studies","volume":"1","author":"Kimura","year":"1996","journal-title":"Genes Cells"},{"key":"2025030417505200800_r16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.immuni.2007.06.009","article-title":"The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8","volume":"27","author":"Tailor","year":"2007","journal-title":"Immunity"},{"key":"2025030417505200800_r17","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1073\/pnas.92.9.3829","article-title":"Tyrosine-phosphorylated Stat1 and Stat2 plus a 48-kDa protein all contact DNA in forming interferon-stimulated-gene factor 3","volume":"92","author":"Qureshi","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030417505200800_r18","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1128\/MCB.19.4.2465","article-title":"Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains","volume":"19","author":"Lin","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"2025030417505200800_r19","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/emboj\/17.4.1087","article-title":"Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP\/p300","volume":"17","author":"Yoneyama","year":"1998","journal-title":"EMBO J."},{"key":"2025030417505200800_r20","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1128\/MCB.18.5.2986","article-title":"Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation","volume":"18","author":"Lin","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"2025030417505200800_r21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/imm.12038","article-title":"Recent advances in understanding viral evasion of type I interferon","volume":"138","author":"Taylor","year":"2013","journal-title":"Immunology"},{"key":"2025030417505200800_r22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1074-7613(00)00053-4","article-title":"Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha\/beta gene induction","volume":"13","author":"Sato","year":"2000","journal-title":"Immunity"},{"key":"2025030417505200800_r23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cellimm.2016.08.015","article-title":"Significant role for IRF3 in both T cell and APC effector functions during T cell responses","volume":"310","author":"Guinn","year":"2016","journal-title":"Cell. Immunol."},{"key":"2025030417505200800_r24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bbrc.2006.01.122","article-title":"Regulation of IRF7 through cell type-specific protein stability","volume":"342","author":"Prakash","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2025030417505200800_r25","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s12026-015-8780-8","article-title":"Cloning and characterizing of the murine IRF-3 gene promoter region","volume":"64","author":"Xu","year":"2016","journal-title":"Immunol. Res."},{"key":"2025030417505200800_r26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00251-010-0505-5","article-title":"Direct repression of the human IRF-3 promoter by E2F1","volume":"63","author":"Xu","year":"2011","journal-title":"Immunogenetics"},{"key":"2025030417505200800_r27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0166-2236(98)01343-5","article-title":"The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience","volume":"22","author":"O\u2019Donovan","year":"1999","journal-title":"Trends Neurosci."},{"key":"2025030417505200800_r28","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/ni1193","article-title":"Egr-2 and Egr-3 are negative regulators of T cell activation. [Published erratum appears in 2005 Nat. Immunol. 6: 737.]","volume":"6","author":"Safford","year":"2005","journal-title":"Nat. Immunol."},{"key":"2025030417505200800_r29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1074-7613(02)00390-4","article-title":"IRF3 mediates a TLR3\/TLR4-specific antiviral gene program","volume":"17","author":"Doyle","year":"2002","journal-title":"Immunity"},{"key":"2025030417505200800_r30","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1084\/jem.20031023","article-title":"LPS-TLR4 signaling to IRF-3\/7 and NF-kappaB involves the toll adapters TRAM and TRIF. [Published erratum appears in 2003 J. Exp. Med. 198: following 1450.]","volume":"198","author":"Fitzgerald","year":"2003","journal-title":"J. Exp. Med."},{"key":"2025030417505200800_r31","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ni1087","article-title":"The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses","volume":"5","author":"Yoneyama","year":"2004","journal-title":"Nat. Immunol."},{"key":"2025030417505200800_r32","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni1243","article-title":"IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction","volume":"6","author":"Kawai","year":"2005","journal-title":"Nat. Immunol."},{"key":"2025030417505200800_r33","doi-asserted-by":"crossref","first-page":"ra20","DOI":"10.1126\/scisignal.2002521","article-title":"STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway","volume":"5","author":"Tanaka","year":"2012","journal-title":"Sci. Signal."},{"key":"2025030417505200800_r34","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1128\/MCB.20.11.4159-4168.2000","article-title":"Regulated nuclear-cytoplasmic localization of interferon regulatory factor 3, a subunit of double-stranded RNA-activated factor 1","volume":"20","author":"Kumar","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"2025030417505200800_r35","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1038\/emboj.2010.50","article-title":"Viral apoptosis is induced by IRF-3-mediated activation of Bax","volume":"29","author":"Chattopadhyay","year":"2010","journal-title":"EMBO J."},{"key":"2025030417505200800_r36","first-page":"6753","article-title":"Interplay between repressing and activating domains defines the transcriptional activity of IRF-1","volume":"267","author":"Kirchhoff","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"2025030417505200800_r37","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1126\/science.1087262","article-title":"Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway","volume":"301","author":"Yamamoto","year":"2003","journal-title":"Science"},{"key":"2025030417505200800_r38","doi-asserted-by":"crossref","first-page":"8676","DOI":"10.4049\/jimmunol.177.12.8676","article-title":"NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type I IFN induction","volume":"177","author":"Sasai","year":"2006","journal-title":"J. Immunol."},{"key":"2025030417505200800_r39","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cell.2005.08.012","article-title":"Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3","volume":"122","author":"Seth","year":"2005","journal-title":"Cell"},{"key":"2025030417505200800_r40","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"key":"2025030417505200800_r41","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nature06013","article-title":"DAI (DLM-1\/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response","volume":"448","author":"Takaoka","year":"2007","journal-title":"Nature"},{"key":"2025030417505200800_r42","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.cell.2007.05.019","article-title":"An atomic model of the interferon-beta enhanceosome","volume":"129","author":"Panne","year":"2007","journal-title":"Cell"},{"key":"2025030417505200800_r43","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nsmb847","article-title":"Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling","volume":"11","author":"Sarkar","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2025030417505200800_r44","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/imm.12373","article-title":"Phosphatidylinositol-3-kinase and Akt are required for RIG-I-mediated anti-viral signalling through cross-talk with IPS-1","volume":"144","author":"Yeon","year":"2015","journal-title":"Immunology"},{"key":"2025030417505200800_r45","doi-asserted-by":"crossref","first-page":"35535","DOI":"10.1074\/jbc.274.50.35535","article-title":"p38-dependent activation of interferon regulatory factor 3 by lipopolysaccharide","volume":"274","author":"Navarro","year":"1999","journal-title":"J. Biol. Chem."},{"key":"2025030417505200800_r46","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0006-2952(02)01165-6","article-title":"Multiple signaling pathways leading to the activation of interferon regulatory factor 3","volume":"64","author":"Servant","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"2025030417505200800_r47","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1016\/j.febslet.2013.07.025","article-title":"IRF3 and ERK MAP-kinases control nitric oxide production from macrophages in response to poly-I:C","volume":"587","author":"Moore","year":"2013","journal-title":"FEBS Lett."},{"key":"2025030417505200800_r48","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1074\/jbc.M007790200","article-title":"Identification of distinct signaling pathways leading to the phosphorylation of interferon regulatory factor 3","volume":"276","author":"Servant","year":"2001","journal-title":"J. Biol. Chem."},{"key":"2025030417505200800_r49","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/ni.1876","article-title":"The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway","volume":"11","author":"Yang","year":"2010","journal-title":"Nat. Immunol."},{"key":"2025030417505200800_r50","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00636-12","article-title":"Inhibition of viral pathogenesis and promotion of the septic shock response to bacterial infection by IRF-3 are regulated by the acetylation and phosphorylation of its coactivators","volume":"4","author":"Chattopadhyay","year":"2013","journal-title":"MBio"},{"key":"2025030417505200800_r51","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1128\/MCB.20.13.4814-4825.2000","article-title":"Assembly of a functional beta interferon enhanceosome is dependent on ATF-2-c-jun heterodimer orientation","volume":"20","author":"Falvo","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"2025030417505200800_r52","first-page":"3756","article-title":"Double-stranded RNA activates novel factors that bind to the interferon-stimulated response element","volume":"13","author":"Daly","year":"1993","journal-title":"Mol. Cell. Biol."},{"key":"2025030417505200800_r53","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1093\/nar\/gky002","article-title":"DNA-binding landscape of IRF3, IRF5 and IRF7 dimers: implications for dimer-specific gene regulation","volume":"46","author":"Andrilenas","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"2025030417505200800_r54","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1074\/jbc.273.5.2714","article-title":"Regulation of type I interferon gene expression by interferon regulatory factor-3","volume":"273","author":"Schafer","year":"1998","journal-title":"J. Biol. Chem."},{"key":"2025030417505200800_r55","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1196\/annals.1299.042","article-title":"Convergence of the NF-kappaB and interferon signaling pathways in the regulation of antiviral defense and apoptosis","volume":"1010","author":"Hiscott","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2025030417505200800_r56","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1074\/jbc.M113.519934","article-title":"Mitogen-activated protein kinase-mediated licensing of interferon regulatory factor 3\/7 reinforces the cell response to virus","volume":"289","author":"Schmid","year":"2014","journal-title":"J. Biol. Chem."},{"key":"2025030417505200800_r57","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1182\/blood-2010-07-294272","article-title":"IRF8 and IRF3 cooperatively regulate rapid interferon-\u03b2 induction in human blood monocytes","volume":"117","author":"Li","year":"2011","journal-title":"Blood"},{"key":"2025030417505200800_r58","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.4049\/jimmunol.181.7.4523","article-title":"Promoter analysis reveals critical roles for SMAD-3 and ATF-2 in expression of IL-23 p19 in macrophages","volume":"181","author":"Al-Salleeh","year":"2008","journal-title":"J. Immunol."},{"key":"2025030417505200800_r59","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.4049\/jimmunol.0903429","article-title":"IFN regulatory factor 3 contributes to the host response during Pseudomonas aeruginosa lung infection in mice","volume":"185","author":"Carrigan","year":"2010","journal-title":"J. Immunol."},{"key":"2025030417505200800_r60","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1073\/pnas.2237236100","article-title":"IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts","volume":"101","author":"McWhirter","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030417505200800_r61","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.imbio.2019.04.004","article-title":"Interferon regulatory factor 3 plays a role in macrophage responses to interferon-\u03b3","volume":"224","author":"Guinn","year":"2019","journal-title":"Immunobiology"},{"key":"2025030417505200800_r62","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/eji.200838832","article-title":"Transcriptional re-programming of primary macrophages reveals distinct apoptotic and anti-tumoral functions of IRF-3 and IRF-7","volume":"39","author":"Goubau","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"2025030417505200800_r63","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virol.2007.03.011","article-title":"Bax-dependent mitochondrial membrane permeabilization enhances IRF3-mediated innate immune response during VSV infection","volume":"365","author":"Sharif-Askari","year":"2007","journal-title":"Virology"},{"key":"2025030417505200800_r64","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.4049\/jimmunol.176.12.7462","article-title":"Differential activation of IFN regulatory factor (IRF)-3 and IRF-5 transcription factors during viral infection","volume":"176","author":"Cheng","year":"2006","journal-title":"J. Immunol."},{"key":"2025030417505200800_r65","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1128\/JVI.02133-10","article-title":"The IRF-3\/Bax-mediated apoptotic pathway, activated by viral cytoplasmic RNA and DNA, inhibits virus replication","volume":"85","author":"Chattopadhyay","year":"2011","journal-title":"J. Virol."},{"key":"2025030417505200800_r66","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.immuni.2016.04.009","article-title":"Ubiquitination of the transcription factor IRF-3 activates RIPA, the apoptotic pathway that protects mice from viral pathogenesis","volume":"44","author":"Chattopadhyay","year":"2016","journal-title":"Immunity"},{"key":"2025030417505200800_r67","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1128\/JVI.01099-08","article-title":"Epstein-barr virus BGLF4 kinase suppresses the interferon regulatory factor 3 signaling pathway","volume":"83","author":"Wang","year":"2009","journal-title":"J. Virol."},{"key":"2025030417505200800_r68","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1128\/MCB.00344-15","article-title":"Fine-tuning of the RIG-I-like receptor\/interferon regulatory factor 3-dependent antiviral innate immune response by the glycogen synthase kinase 3\/\u03b2-catenin pathway","volume":"35","author":"Khan","year":"2015","journal-title":"Mol. Cell. Biol."},{"key":"2025030417505200800_r69","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/1753425913485307","article-title":"Glycogen synthase kinase 3 negatively regulates IFN regulatory factor 3 transactivation through phosphorylation at its linker region","volume":"20","author":"Wang","year":"2014","journal-title":"Innate Immun."},{"key":"2025030417505200800_r70","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.immuni.2010.11.027","article-title":"The ubiquitin E3 ligase RAUL negatively regulates type i interferon through ubiquitination of the transcription factors IRF7 and IRF3","volume":"33","author":"Yu","year":"2010","journal-title":"Immunity"},{"key":"2025030417505200800_r71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004726","article-title":"TRIM26 negatively regulates interferon-\u03b2 production and antiviral response through polyubiquitination and degradation of nuclear IRF3","volume":"11","author":"Wang","year":"2015","journal-title":"PLoS Pathog."},{"key":"2025030417505200800_r72","doi-asserted-by":"crossref","first-page":"12596","DOI":"10.1074\/jbc.M112.444794","article-title":"FoxO1 negatively regulates cellular antiviral response by promoting degradation of IRF3","volume":"288","author":"Lei","year":"2013","journal-title":"J. Biol. Chem."},{"key":"2025030417505200800_r73","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/ni1347","article-title":"Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1","volume":"7","author":"Saitoh","year":"2006","journal-title":"Nat. Immunol."},{"key":"2025030417505200800_r74","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1084\/jem.20181773","article-title":"KAT8 selectively inhibits antiviral immunity by acetylating IRF3. [Published erratum appears in 2019 J. Exp. Med. 216: 1001.]","volume":"216","author":"Huai","year":"2019","journal-title":"J. Exp. Med."},{"key":"2025030417505200800_r75","doi-asserted-by":"crossref","first-page":"923","DOI":"10.4049\/jimmunol.1502611","article-title":"cFLIPL interrupts IRF3-CBP-DNA interactions to inhibit IRF3-driven transcription","volume":"197","author":"Gates","year":"2016","journal-title":"J. Immunol."},{"key":"2025030417505200800_r76","doi-asserted-by":"crossref","first-page":"10561","DOI":"10.1074\/jbc.RA117.001491","article-title":"C6orf106 is a novel inhibitor of the interferon-regulatory factor 3-dependent innate antiviral response","volume":"293","author":"Ambrose","year":"2018","journal-title":"J. Biol. Chem."},{"key":"2025030417505200800_r77","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01159-19","article-title":"Novel functions of IFI44L as a feedback regulator of host antiviral responses","volume":"93","author":"DeDiego","year":"2019","journal-title":"J. Virol."},{"key":"2025030417505200800_r78","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1016\/j.cellsig.2014.09.007","article-title":"Protein phosphatase PP1 negatively regulates the toll-like receptor- and RIG-I-like receptor-triggered production of type I interferon by inhibiting IRF3 phosphorylation at serines 396 and 385 in macrophage","volume":"26","author":"Gu","year":"2014","journal-title":"Cell. Signal."},{"key":"2025030417505200800_r79","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.celrep.2015.02.030","article-title":"MAPK phosphatase 5 expression induced by influenza and other RNA virus infection negatively regulates IRF3 activation and type I interferon response","volume":"10","author":"James","year":"2015","journal-title":"Cell Rep."},{"key":"2025030417505200800_r80","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1084\/jem.20170856","article-title":"The methyltransferase NSD3 promotes antiviral innate immunity via direct lysine methylation of IRF3","volume":"214","author":"Wang","year":"2017","journal-title":"J. Exp. Med."},{"key":"2025030417505200800_r81","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ni.3311","article-title":"The tumor suppressor PTEN has a critical role in antiviral innate immunity","volume":"17","author":"Li","year":"2016","journal-title":"Nat. Immunol."},{"key":"2025030417505200800_r82","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1128\/MCB.01466-09","article-title":"Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification","volume":"30","author":"Shi","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"2025030417505200800_r83","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1128\/MCB.21.13.4169-4176.2001","article-title":"Functional characterization of interferon regulatory factor 3a (IRF-3a), an alternative splice isoform of IRF-3","volume":"21","author":"Karpova","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"2025030417505200800_r84","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/cmi.2010.55","article-title":"Interferon regulatory factor 3-CL, an isoform of IRF3, antagonizes activity of IRF3","volume":"8","author":"Li","year":"2011","journal-title":"Cell. Mol. Immunol."},{"key":"2025030417505200800_r85","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1371\/journal.pgen.0030152","article-title":"Irf3 polymorphism alters induction of interferon beta in response to Listeria monocytogenes infection","volume":"3","author":"Garifulin","year":"2007","journal-title":"PLoS Genet."},{"key":"2025030417505200800_r86","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1084\/jem.20142274","article-title":"Functional IRF3 deficiency in a patient with herpes simplex encephalitis","volume":"212","author":"Andersen","year":"2015","journal-title":"J. Exp. Med."},{"key":"2025030417505200800_r87","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.virol.2018.10.003","article-title":"Tumor suppressor interferon regulatory factor 1 selectively blocks expression of endogenous retrovirus","volume":"526","author":"Stoltz","year":"2019","journal-title":"Virology"},{"key":"2025030417505200800_r88","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0171-2985(82)80093-4","article-title":"T lymphocyte-macrophage interactions in cellular antibacterial immunity","volume":"161","author":"Hahn","year":"1982","journal-title":"Immunobiology"},{"key":"2025030417505200800_r89","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1462-5822.2007.01114.x","article-title":"Type I IFN are host modulators of strain-specific Listeria monocytogenes virulence","volume":"10","author":"Reutterer","year":"2008","journal-title":"Cell. Microbiol."},{"key":"2025030417505200800_r90","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1016\/j.febslet.2006.03.057","article-title":"Cytoplasmic Listeria monocytogenes stimulates IFN-beta synthesis without requiring the adapter protein MAVS","volume":"580","author":"Soulat","year":"2006","journal-title":"FEBS Lett."},{"key":"2025030417505200800_r91","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.4049\/jimmunol.169.11.6522","article-title":"Production of type I IFN sensitizes macrophages to cell death induced by Listeria monocytogenes","volume":"169","author":"Stockinger","year":"2002","journal-title":"J. Immunol."},{"key":"2025030417505200800_r92","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.4049\/jimmunol.173.12.7416","article-title":"IFN regulatory factor 3-dependent induction of type I IFNs by intracellular bacteria is mediated by a TLR- and Nod2-independent mechanism","volume":"173","author":"Stockinger","year":"2004","journal-title":"J. Immunol."},{"key":"2025030417505200800_r93","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.chom.2012.03.007","article-title":"Mycobacterium tuberculosis activates the DNA-dependent cytosolic surveillance pathway within macrophages","volume":"11","author":"Manzanillo","year":"2012","journal-title":"Cell Host Microbe"},{"key":"2025030417505200800_r94","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1084\/jem.20180508","article-title":"Mycobacterium tuberculosis-induced IFN-\u03b2 production requires cytosolic DNA and RNA sensing pathways","volume":"215","author":"Cheng","year":"2018","journal-title":"J. Exp. Med."},{"key":"2025030417505200800_r95","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cyto.2017.10.006","article-title":"Mycobacterium tuberculosis ESAT6 induces IFN-\u03b2 gene expression in macrophages via TLRs-mediated signaling","volume":"104","author":"Jang","year":"2018","journal-title":"Cytokine"},{"key":"2025030417505200800_r96","doi-asserted-by":"crossref","first-page":"36173","DOI":"10.1074\/jbc.M604638200","article-title":"Legionella pneumophila induces IFNbeta in lung epithelial cells via IPS-1 and IRF3, which also control bacterial replication","volume":"281","author":"Opitz","year":"2006","journal-title":"J. Biol. Chem."},{"key":"2025030417505200800_r97","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nature02405","article-title":"The protein kinase PKR is required for macrophage apoptosis after activation of toll-like receptor 4","volume":"428","author":"Hsu","year":"2004","journal-title":"Nature"},{"key":"2025030417505200800_r98","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3389\/fimmu.2019.00474","article-title":"DNA sensor IFI204 contributes to host defense against Staphylococcus aureus infection in mice","volume":"10","author":"Chen","year":"2019","journal-title":"Front. Immunol."},{"key":"2025030417505200800_r99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001345","article-title":"Type I interferon production induced by Streptococcus pyogenes-derived nucleic acids is required for host protection","volume":"7","author":"Gratz","year":"2011","journal-title":"PLoS Pathog."},{"key":"2025030417505200800_r100","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1016\/j.celrep.2016.05.030","article-title":"Type I interferon induction by Neisseria gonorrhoeae: dual requirement of cyclic GMP-AMP synthase and toll-like receptor 4","volume":"15","author":"Andrade","year":"2016","journal-title":"Cell Rep."},{"key":"2025030417505200800_r101","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/nm.2403","article-title":"DNA released from dying host cells mediates aluminum adjuvant activity","volume":"17","author":"Marichal","year":"2011","journal-title":"Nat. Med."},{"key":"2025030417505200800_r102","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.micinf.2015.03.001","article-title":"IRF3 deficiency impacts granzyme B expression and maintenance of memory T cell function in response to viral infection","volume":"17","author":"Moore","year":"2015","journal-title":"Microbes Infect."},{"key":"2025030417505200800_r103","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1742-2094-11-130","article-title":"Interferon regulatory factor (IRF) 3 is critical for the development of experimental autoimmune encephalomyelitis","volume":"11","author":"Fitzgerald","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"2025030417505200800_r104","doi-asserted-by":"crossref","first-page":"E3189","DOI":"10.1073\/pnas.1219221110","article-title":"Interferon regulatory factor 3 controls interleukin-17 expression in CD8 T lymphocytes","volume":"110","author":"Ysebrant de Lendonck","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030417505200800_r105","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.4049\/jimmunol.1700782","article-title":"IFN regulatory factor 3 balances Th1 and T follicular helper immunity during nonlethal blood-stage Plasmodium infection","volume":"200","author":"James","year":"2018","journal-title":"J. Immunol."},{"key":"2025030417505200800_r106","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1002\/eji.201646513","article-title":"Interferon response factor-3 promotes the pro-Th2 activity of mouse lung CD11b+ conventional dendritic cells in response to house dust mite allergens","volume":"46","author":"Janss","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"2025030417505200800_r107","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jaci.2010.06.009","article-title":"Interferon response factor 3 is essential for house dust mite-induced airway allergy","volume":"126","author":"Marichal","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"2025030417505200800_r108","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.molmed.2017.07.008","article-title":"Putting glioblastoma in its place: IRF3 inhibits invasion","volume":"23","author":"Pattwell","year":"2017","journal-title":"Trends Mol. Med."},{"key":"2025030417505200800_r109","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11060-013-1109-3","article-title":"Interferon regulatory factor 3 alters glioma inflammatory and invasive properties","volume":"113","author":"Tarassishin","year":"2013","journal-title":"J. Neurooncol."},{"key":"2025030417505200800_r110","first-page":"5148","article-title":"In vivo interferon regulatory factor 3 tumor suppressor activity in B16 melanoma tumors","volume":"62","author":"Duguay","year":"2002","journal-title":"Cancer Res."},{"key":"2025030417505200800_r111","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.canlet.2013.12.022","article-title":"Interferon response factor 3 is crucial to poly-I:C induced NK cell activity and control of B16 melanoma growth","volume":"346","author":"Moore","year":"2014","journal-title":"Cancer Lett."},{"key":"2025030417505200800_r112","doi-asserted-by":"crossref","first-page":"30686","DOI":"10.1074\/jbc.274.43.30686","article-title":"Activation of interferon regulatory factor 3 in response to DNA-damaging agents","volume":"274","author":"Kim","year":"1999","journal-title":"J. Biol. Chem."},{"key":"2025030417505200800_r113","doi-asserted-by":"crossref","first-page":"19049","DOI":"10.1038\/srep19049","article-title":"Antitumor activity of cGAMP via stimulation of cGAS-cGAMP-STING-IRF3 mediated innate immune response","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"2025030417505200800_r114","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1158\/2159-8290.CD-18-1020","article-title":"Targeting DNA damage response promotes antitumor immunity through STING-mediated T-cell activation in small cell lung cancer","volume":"9","author":"Sen","year":"2019","journal-title":"Cancer Discov."},{"key":"2025030417505200800_r115","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1158\/0008-5472.CAN-13-1703","article-title":"RAE1 ligands for the NKG2D receptor are regulated by STING-dependent DNA sensor pathways in lymphoma","volume":"74","author":"Lam","year":"2014","journal-title":"Cancer Res."},{"key":"2025030417505200800_r116","doi-asserted-by":"crossref","first-page":"11133","DOI":"10.1158\/0008-5472.CAN-07-1342","article-title":"Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells","volume":"67","author":"Kim","year":"2007","journal-title":"Cancer Res."},{"key":"2025030417505200800_r117","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201797858","article-title":"Attenuation of cGAS-STING signaling is mediated by a p62\/SQSTM1-dependent autophagy pathway activated by TBK1","volume":"37","author":"Prabakaran","year":"2018","journal-title":"EMBO J."},{"key":"2025030417505200800_r118","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/hep.26751","article-title":"Interferon regulatory factor 3 constrains IKK\u03b2\/NF-\u03baB signaling to alleviate hepatic steatosis and insulin resistance","volume":"59","author":"Wang","year":"2014","journal-title":"Hepatology"},{"key":"2025030417505200800_r119","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.virol.2010.09.012","article-title":"Influenza A virus strains that circulate in humans differ in the ability of their NS1 proteins to block the activation of IRF3 and interferon-\u03b2 transcription","volume":"408","author":"Kuo","year":"2010","journal-title":"Virology"},{"key":"2025030417505200800_r120","doi-asserted-by":"crossref","first-page":"8411","DOI":"10.1128\/JVI.78.16.8411-8420.2004","article-title":"Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production","volume":"78","author":"Melroe","year":"2004","journal-title":"J. Virol."},{"key":"2025030417505200800_r121","doi-asserted-by":"crossref","first-page":"11079","DOI":"10.1128\/JVI.05098-11","article-title":"Varicella-zoster virus immediate-early protein ORF61 abrogates the IRF3-mediated innate immune response through degradation of activated IRF3","volume":"85","author":"Zhu","year":"2011","journal-title":"J. Virol."},{"key":"2025030417505200800_r122","doi-asserted-by":"crossref","first-page":"8262","DOI":"10.1128\/JVI.00226-08","article-title":"West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction","volume":"82","author":"Wilson","year":"2008","journal-title":"J. Virol."},{"key":"2025030417505200800_r123","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1128\/JVI.01326-09","article-title":"Porcine reproductive and respiratory syndrome virus nonstructural protein 1beta modulates host innate immune response by antagonizing IRF3 activation","volume":"84","author":"Beura","year":"2010","journal-title":"J. Virol."},{"key":"2025030417505200800_r124","doi-asserted-by":"crossref","first-page":"8367","DOI":"10.1128\/JVI.00423-12","article-title":"Vpu mediates depletion of interferon regulatory factor 3 during HIV infection by a lysosome-dependent mechanism","volume":"86","author":"Doehle","year":"2012","journal-title":"J. Virol."},{"key":"2025030417505200800_r125","doi-asserted-by":"crossref","first-page":"10395","DOI":"10.1128\/JVI.00849-09","article-title":"Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells","volume":"83","author":"Doehle","year":"2009","journal-title":"J. Virol."},{"key":"2025030417505200800_r126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002169","article-title":"Disruption of TLR3 signaling due to cleavage of TRIF by the hepatitis A virus protease-polymerase processing intermediate, 3CD","volume":"7","author":"Qu","year":"2011","journal-title":"PLoS Pathog."},{"key":"2025030417505200800_r127","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1099\/vir.0.005678-0","article-title":"Inhibition of mRNA export and dimerization of interferon regulatory factor 3 by Theiler\u2019s virus leader protein","volume":"90","author":"Ricour","year":"2009","journal-title":"J. Gen. Virol."},{"key":"2025030417505200800_r128","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1042\/BCJ20161037","article-title":"Encephalomyocarditis virus 3C protease attenuates type I interferon production through disrupting the TANK-TBK1-IKK\u03b5-IRF3 complex","volume":"474","author":"Huang","year":"2017","journal-title":"Biochem. J."},{"key":"2025030417505200800_r129","doi-asserted-by":"crossref","first-page":"8194","DOI":"10.1128\/JVI.74.17.8194-8201.2000","article-title":"Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors","volume":"74","author":"Lubyova","year":"2000","journal-title":"J. Virol."},{"key":"2025030417505200800_r130","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fimmu.2020.00051","article-title":"NS5 conservative site is required for zika virus to restrict the RIG-I signaling","volume":"11","author":"Li","year":"2020","journal-title":"Front. Immunol."},{"key":"2025030417505200800_r131","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00553-15","article-title":"Dengue virus NS proteins inhibit RIG-I\/MAVS signaling by blocking TBK1\/IRF3 phosphorylation: dengue virus serotype 1 NS4A is a unique interferon-regulating virulence determinant","volume":"6","author":"Dalrymple","year":"2015","journal-title":"MBio"},{"key":"2025030417505200800_r132","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.virol.2010.03.014","article-title":"Epstein-barr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-beta","volume":"402","author":"Bentz","year":"2010","journal-title":"Virology"},{"key":"2025030417505200800_r133","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2016.33","article-title":"Middle east respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3","volume":"5","author":"Lui","year":"2016","journal-title":"Emerg. Microbes Infect."},{"key":"2025030417505200800_r134","doi-asserted-by":"crossref","first-page":"16202","DOI":"10.1074\/jbc.M109.008227","article-title":"Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1\/IKKepsilon complex","volume":"284","author":"Siu","year":"2009","journal-title":"J. Biol. Chem."},{"key":"2025030417505200800_r135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11262-010-0544-x","article-title":"SARS-CoV nucleocapsid protein antagonizes IFN-\u03b2 response by targeting initial step of IFN-\u03b2 induction pathway, and its C-terminal region is critical for the antagonism","volume":"42","author":"Lu","year":"2011","journal-title":"Virus Genes"},{"key":"2025030417505200800_r136","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s13238-014-0026-3","article-title":"SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex","volume":"5","author":"Chen","year":"2014","journal-title":"Protein Cell"},{"key":"2025030417505200800_r137","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12519-019-00273-z","article-title":"Toward a better understanding of type I interferonopathies: a brief summary, update and beyond","volume":"16","author":"Yu","year":"2020","journal-title":"World J. Pediatr."},{"key":"2025030417505200800_r138","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1312625","article-title":"Activated STING in a vascular and pulmonary syndrome","volume":"371","author":"Liu","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"2025030417505200800_r139","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.3389\/fimmu.2019.02770","article-title":"Novel TMEM173 mutation and the role of disease modifying alleles","volume":"10","author":"Keskitalo","year":"2019","journal-title":"Front. Immunol."},{"key":"2025030417505200800_r140","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jaci.2016.10.031","article-title":"Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling. [Published erratum appears in 2017 J. Allergy Clin. Immunol. 140: 1757.]","volume":"140","author":"Melki","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"2025030417505200800_r141","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.autrev.2012.08.012","article-title":"Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder?","volume":"12","author":"Fazzi","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"2025030417505200800_r142","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.molimm.2018.08.005","article-title":"SAMHD1 deficient human monocytes autonomously trigger type I interferon","volume":"101","author":"Martinez-Lopez","year":"2018","journal-title":"Mol. Immunol."},{"key":"2025030417505200800_r143","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41598-017-18308-8","article-title":"A central role for PI3K-AKT signaling pathway in linking SAMHD1-deficiency to the type I interferon signature","volume":"8","author":"Oh","year":"2018","journal-title":"Sci. Rep."},{"key":"2025030417505200800_r144","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/nm.4428","article-title":"IRF3 and type I interferons fuel a fatal response to myocardial infarction","volume":"23","author":"King","year":"2017","journal-title":"Nat. Med."},{"key":"2025030417505200800_r145","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.virol.2011.06.028","article-title":"IRF3 polymorphisms induce different innate anti-Theiler's virus immune responses in RAW264.7 macrophages","volume":"418","author":"Moore","year":"2011","journal-title":"Virology"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/205\/8\/1981\/61881122\/ji2000462.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/205\/8\/1981\/61881122\/ji2000462.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T18:13:24Z","timestamp":1741112004000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/205\/8\/1981\/7931012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":145,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,10,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.2000462","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,10]]}}}